Harris Matthew Scott

Chief Medical OfficerAltimmune, Inc. (ALT) · full profile →Form 4 · filed Feb 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
7 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2025Option exercise(M)8K$085K
Feb 2, 2025Tax withholding(F)3K$6.64$18K82K
Feb 1, 2025Tax withholding(F)2K$6.64$14K77K
Feb 1, 2025Option exercise(M)6K$079K
Jan 31, 2025Grant(A)2K$5.18$10K73K
Jan 30, 2025Option exercise(M)9K$074K
Jan 30, 2025Tax withholding(F)3K$7.00$22K71K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2025Option exercise(M)8K$08K
Feb 1, 2025Option exercise(M)6K$00
Jan 30, 2025Option exercise(M)9K$019K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-008772) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ALT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-25-008772"
Ask your agent
Use Arkolith to summarize insider buying and selling at Altimmune, Inc.
over the last 90 days and cite the filings.